Eli Lilly Becomes First Drugmaker With GLP-1 Weight-Loss Pill Approved in China
China's approval marks a regulatory milestone for Eli Lilly's weight-loss pill.
Related stories
State Street Corp Raises Share Stake In Nvidia By 1.5% To 1.03 Bln Shares - SEC Filing
L impact | REGULATION | Nov 12, 2026, 11:39 AM UTC
State Street Corp Raises Share Stake In SpaceX By 77.8% To 19.3 Mln Class A Shares - SEC Filing
L impact | REGULATION | Nov 12, 2026, 11:37 AM UTC
UK Ofcom Fines Meta $596,700 Over WhatsApp Business Information
Meta Platforms was fined by the UK's Ofcom over inaccurate WhatsApp Business information.
M impact | REGULATION | Nov 12, 2026, 11:29 AM UTC
NYSE American Suspends AtlasClear Trading and Starts Delisting Proceedings
NYSE American notified AtlasClear Holdings on November 10 that it suspended trading in the company’s common stock and began delisting proceedings, citing its low selling price.
M impact | REGULATION | Nov 12, 2026, 11:15 AM UTC
UK Regulator Fines Meta Over WhatsApp Business Data Inaccuracies
The UK regulator fined Meta over repeated inaccuracies in WhatsApp Business data.
M impact | REGULATION | Nov 12, 2026, 11:11 AM UTC
US FDA Shelved Fast-Track Drug Review Initiative Launched By Former Commissioner Makary — RTRS Cites Sources, Documents
L impact | REGULATION | Nov 12, 2026, 11:01 AM UTC